FDA 483 - Strides Pharma Science Limited - May 24, 2019
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of Strides Pharma Science Limited in Bangalore, Karnataka, India, a manufacturer of finished drugs, revealed significant deficiencies in quality control and manufacturing processes. The firm failed to conduct complete investigations into out-of-specification results and unexplained discrepancies, and lacked adequate control procedures for monitoring manufacturing processes and environmental conditions. Additionally, laboratory controls for media acceptance were found to be deficient.
ID · 6aba0508-6d58-45c8-abe2-72447d775be9